(Q40395365)

20 September 2017

1 reference

title

CD40-mediated regulation of human B-cell responses (English)

1 reference

20 September 2017

J B Splawski

1

1 reference

PubMed ID

7527580

20 September 2017

P E Lipsky

series ordinal

2

1 reference

20 September 2017

1 March 1994

1 reference

20 September 2017

Research in Immunology

1 reference

20 September 2017

145

1 reference

20 September 2017

3

1 reference

20 September 2017

226-34; discussion 244-9

1 reference

CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40.

20 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2894%2980189-4

7 January 2021

CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2894%2980189-4

7 January 2021

Molecular and biological characterization of a murine ligand for CD40

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2894%2980189-4

7 January 2021

The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2894%2980189-4

7 January 2021

Long-Term Human B Cell Lines Dependent on Interleukin-4 and antibody to CD40

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2894%2980189-4

7 January 2021

Expression of CD40 and CD43 during Activation of Human B Lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2894%2980189-4

7 January 2021

Recombination between immunoglobulin variable region gene segments is enhanced by transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2894%2980189-4

7 January 2021

Functional properties of human germinal center B cells

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2894%2980189-4

7 January 2021

CD40 ligand and its role in X-linked hyper-IgM syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2894%2980189-4

7 January 2021

Interleukin 10 and transforming growth factor beta cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A.

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2894%2980189-4

7 January 2021

CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2894%2980189-4

7 January 2021

In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39.

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2894%2980189-4

7 January 2021

Cyclosporin A inhibits CD40 ligand expression in T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2894%2980189-4

7 January 2021

Human CD40-ligand: molecular cloning, cellular distribution and regulation of expression by factors controlling IgE production

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2894%2980189-4

7 January 2021

Induction of human IgE synthesis in B cells by mast cells and basophils

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2894%2980189-4

7 January 2021

Structure and expression of germline epsilon transcripts in human B cells induced by interleukin 4 to switch to IgE production

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2894%2980189-4

7 January 2021

Cloning of TRAP, a ligand for CD40 on human T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2894%2980189-4

7 January 2021

Isolation and characterization of human tonsil dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2894%2980189-4

7 January 2021

CD40 and IgE: synergism between anti-CD40 monoclonal antibody and interleukin 4 in the induction of IgE synthesis by highly purified human B cells

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2894%2980189-4

7 January 2021

Distribution of cAMP in secondary follicles and its expression in B cell apoptosis and CD40-mediated survival

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2894%2980189-4

7 January 2021

Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2894%2980189-4

7 January 2021

T cell-dependent induction of NF-kappa B in B cells

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2894%2980189-4

7 January 2021

Activated human T cells express a ligand for the human B cell-associated antigen CD40 which participates in T cell-dependent activation of B lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2894%2980189-4

7 January 2021

Hyper IgM immunodeficiency. A primary dysfunction of B lymphocyte isotype switching

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2894%2980189-4

7 January 2021

Mechanism of antigen-driven selection in germinal centres

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2894%2980189-4

7 January 2021

Mitogen- and IL-4-regulated expression of germ-line Ig gamma 2b transcripts: evidence for directed heavy chain class switching

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2894%2980189-4

7 January 2021

A new superfamily of cell surface proteins related to the nerve growth factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2894%2980189-4

7 January 2021

CD40 and its ligand, an essential ligand-receptor pair for thymus-dependent B-cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2894%2980189-4

7 January 2021

B cell activation via CD40 is required for specific antibody production by antigen-stimulated human B cells

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2894%2980189-4

7 January 2021

Mapping of the X-linked form of hyper-IgM syndrome (HIGM1) to Xq26 by close linkage to HPRT

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2894%2980189-4

7 January 2021

Cytokine-induced proliferation and immunoglobulin production of human B lymphocytes triggered through their CD40 antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2894%2980189-4

7 January 2021

Molecular cloning and expression of a receptor for human tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2894%2980189-4

7 January 2021

Isolated human follicular dendritic cells display a unique antigenic phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2894%2980189-4

7 January 2021

Molecular analysis of the induction of immunoglobulin E synthesis in human B cells by interleukin 4 and engagement of CD40 antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2894%2980189-4

7 January 2021

Production of sterile transcripts of C gamma genes in an IgM-producing human neoplastic B cell line that switches to IgG-producing cells

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2894%2980189-4

7 January 2021

A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2894%2980189-4

7 January 2021

Delineation of the functional capacity of human neonatal lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2894%2980189-4

7 January 2021

Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2894%2980189-4

7 January 2021

Induction of immunoglobulin isotype switching in cultured I.29 B lymphoma cells. Characterization of the accompanying rearrangements of heavy chain genes

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2894%2980189-4

7 January 2021

Activation of human B lymphocytes through CD40 and interleukin 4

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2894%2980189-4

7 January 2021

10.1016/S0923-2494(94)80189-4

Identifiers

DOI

1 reference

20 September 2017

1 reference

PubMed ID

7527580